TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›OHI

OHI

OMEGA HEALTHCARE INVESTORS INC

Next earnings Jul 29, 2026 · consensus $0.48 EPS, $305M rev

Last earnings +1.6% on 2026-04-28

Hold
$49.40
▲ +2.68%
$49.40▲ +43.72%
over 1Y
L $34.10H $49.40
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+2.7%
1W+3.7%
1M+10.2%
3M+11.4%
YTD+14.2%
1Y+43.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B+
Valuation
Undervalued
Filings
Watch
Hold
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 22 analysts
Buy

Recovering SNF-focused REIT with rising revenue and a deleveraged balance sheet, but the $780M dividend outruns net income.

Revenue $1.19B · FY2025

The read

Middling fundamentals offset by an attractive price (~49% below fair value) — worth a look on the value angle.

Omega Healthcare Investors is a skilled-nursing-facility (SNF) and assisted-living REIT that has staged a clear recovery. FY2025 revenue grew 13.2% to $1.19B and net income jumped 45.2% to $590M, with diluted EPS up 25.2% to $1.94, extending a turnaround from the COVID-era trough. As a REIT the relevant cash measure is operating cash flow, which rose 17.2% to $879M — strong coverage that funds the business and most of the dividend. Operating margin of 46.4% and net margin of 49.6% reflect the high-margin triple-net lease model across 1,027 facilities operated by 89 third-party operators.

The balance sheet has improved markedly: total liabilities fell 10.8% to $4.61B and long-term debt dropped 12.0% to $4.26B, while equity rose 14.2% to $5.18B, leaving a conservative 0.89x liabilities-to-equity ratio. The newly adopted RIDEA structure (begun Q4 2025) lets Omega capture operating upside at select facilities beyond fixed rents, a potential growth lever.

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:45 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$1.06B$878M$950M$1.05B$1.19B
Gross profit—————
Operating income—————
Net income——$242M$406M$590M
Diluted EPS$1.75$1.80$1.00$1.55$1.94
Net margin——25.5%38.6%49.6%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)0.56
Earnings yield3.8%
FCF yield—

Quality & risk

ROIC (est.)4.6%
Free cash flow—
Total debt$4.26B
Net cash-$4.23B
Piotroski F-Score6/7

Capital returns

Buyback yield0.9%
Dividend yield (est.)5.1%
Shareholder yield6.0%
Shares Δ YoY+4.9%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Shareholder vote2026-06-05
  2. 8-K Officer / director change2026-05-21
  3. 10-Q Quarterly report2026-04-29
  4. 8-K Earnings results2026-04-28
  5. DEF 14A Proxy statement2026-04-21
  6. 10-K Annual report2026-02-09
  7. 8-K Earnings results2026-02-04
  8. 8-K Officer / director change2026-01-07
  9. 8-K Other event2025-11-03

Recent filings

all on EDGAR ↗
4Period ending 2026-06-302026-07-01open ↗4Period ending 2026-06-302026-07-01open ↗4Period ending 2026-06-302026-07-01open ↗4Period ending 2026-06-302026-07-01open ↗4Period ending 2026-06-302026-07-01open ↗4Period ending 2026-06-302026-07-01open ↗4Period ending 2026-06-052026-06-09open ↗4Period ending 2026-06-052026-06-09open ↗4Period ending 2026-06-052026-06-09open ↗4Period ending 2026-06-052026-06-09open ↗4Period ending 2026-06-052026-06-09open ↗4Period ending 2026-06-052026-06-09open ↗

Quality score

B+
ValueGrowthProfitHealthMom.
ValueD
GrowthA
ProfitabilityA
Financial healthA-
MomentumA+
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✗Return on equity above 15%
  • ✗P/E below 25

Fair value est.

$73.72

Undervalued +49% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.94 × (8.5 + 1.5 × 22.0% growth) × 1.05 quality = 38.0× multiple. An estimate, not a price target.

34.1052-week49.40
Revenue
$1.19B
+13.2% YoY
Net margin
49.6%
ROE
11.4%
P/E
25.5

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$1.19B+13.2%
Net income$590M+45.2%
Operating income$552M+10.9%
Diluted EPS$1.94+25.2%
Cash & equivalents$27.0M-94.8%
Total assets$10.0B+1.5%
Total liabilities$4.61B-10.8%
Stockholders' equity$5.18B+14.2%
Op.: 46.4%L/E: 0.89x

Frequently asked

Is OMEGA HEALTHCARE INVESTORS INC (OHI) a buy?
OHI currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Recovering SNF-focused REIT with rising revenue and a deleveraged balance sheet, but the $780M dividend outruns net income.
What is OHI's fair value?
A Modified-Graham model based on OHI's SEC fundamentals estimates a fair value of about $73.72. It is an estimate from reported earnings, not a price target.
Is OHI overvalued or undervalued?
Against a Modified-Graham fair-value estimate, OHI currently appears undervalued relative to its SEC-grounded earnings power.
What is OMEGA HEALTHCARE INVESTORS INC's quality score?
OHI scores 78.2522032841405/100 (grade B+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000888491, latest 10-Q filed 2026-04-29) · EODHD · Proprietary analysis · as of 6/21/2026, 8:45:00 PM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-07-01
Ballew Neal
CHIEF ACCOUNTING OFFICER
Award168.00 @ $37.25$6.26K
2026-07-01
Ballew Neal
CHIEF ACCOUNTING OFFICER
Disposed (D)11.00 @ $47.68$524.48
2026-06-05
WHITMAN BURKE W
Director
Award3.78K @ $43.67$165K

Dividends

Quarterly
Yield (TTM)
5.4%
Annual / share
$2.68
Last ex-date
2026-05-04
Last amount
$0.67
ex 2026-05-04paid 2026-05-15$0.67
ex 2026-02-09paid 2026-02-17$0.67
ex 2025-11-03paid 2025-11-17$0.67
ex 2025-08-04paid 2025-08-15$0.67
ex 2025-05-05paid 2025-05-15$0.67
ex 2025-02-10paid 2025-02-18$0.67

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-04-28Beat +3.9% est▲ +1.61%8-K ↗
2026-02-04Beat +12.7% est▲ +0.07%8-K ↗
2025-10-30Beat +30.4% est▲ +0.86%8-K ↗
2025-07-31Beat +6.4% est▲ +0.18%8-K ↗
2025-05-01—▼ -1.25%8-K ↗
2025-02-05—▲ +1.92%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2023-04-17Daniel GoldmanSell$1.00K–$15.0KPTR ↗
2018-02-14Greg GianforteBuy$50.0K–$100KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
Omega Announces Second Quarter Earnings Release Date and Conference CallBullish
finance.yahoo.com· 2026-07-02
PINE vs. OHI: Which Stock Should Value Investors Buy Now?Bullish
finance.yahoo.com· 2026-06-29
Omega Healthcare Investors (OHI) Stock Valuation Check After Recent Mixed Performance And Income AppealBullish
finance.yahoo.com· 2026-06-13
Is Sonida Senior Living, Inc. (SNDA) A Good Stock To Buy Now?Bullish
finance.yahoo.com· 2026-06-13
PINE or OHI: Which Is the Better Value Stock Right Now?Bullish
finance.yahoo.com· 2026-06-11
Bristol-Myers Upgraded, Broadcom Downgraded: Updated Rankings on Top Blue-Chip StocksBullish
finance.yahoo.com· 2026-06-08

Vs tracked universe

compare →

1194 tracked peers · median

TENK Score78 vs 67
Revenue growth13.2% vs 7.5%
Net margin49.6% vs 10.0%
Return on equity11.4% vs 12.0%
P/E25.5 vs 26.2

News sentiment

EODHD · 14d
Bullish
+0.17
vs typical · 16 articles

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.